- Presentations
- 2
- Markets
- 1
Glycophos is a brand of Sodium glycerophosphate marketed by Fresenius Kabi, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sodium glycerophosphate
- Brand owner
- Fresenius Kabi
- Registered in
- United States
- Strengths and forms
- 21600 mg/100 mL injection, 4320 mg/20 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Glycophos 21600 mg/100 mL injectionIntravenous Cold chain | Fresenius Kabi | US FDA | Available on request |
| Glycophos 4320 mg/20 mL injectionIntravenous Cold chain | Fresenius Kabi | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Glycophos
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.